Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 3180-3183

  Odds, F C ^a   Oris, M ^a   Van Dorsselaer, P ^a   Van Gerven, F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLODEXTRIN; ITRACONAZOLE; PLACEBO;

ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; GUINEA PIGS; ITRACONAZOLE; TREATMENT OUTCOME;

EID: 0033735320     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.3180-3183.2000     Document Type: Article

References (21)

1. Evaluation of water-soluble pneumocandin analogs L-733560 L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
2. Amphotericin B lipid complex therapy of experimental fungal infections in mice
3. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis
4. International conference for the development of a consensus on the management and prevention of severe candidal infections
5. Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia
6. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients
7. Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients
8. Endemic mycoses: A treatment update
9. Treatment of paracoccidioidomycosis with itraconazole in a murine model
10. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS
11. Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: Meeting report. London, United Kingdom, 20 June 1998
12. Amphotericin B-refractory aspergillosis after itraconazole - Evidence for significant antagonism
13. Current and emerging azole antifungal agents
14. Clinical study of itraconazole for systemic fungal infections complicated with hematological malignancies - Multicenter cooperative study. West-Japan Systemic Fungal Infection Study Group
15. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients
16. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy
17. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents
18. Effect of food on the pharmacodynamics of a new hydroxypropyl-β-cyclodextrin formulation of itraconazole
19. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units
20. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection
21. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection